| __timestamp | Dynavax Technologies Corporation | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 11032000 | 152381 |
| Thursday, January 1, 2015 | 4050000 | 152381 |
| Friday, January 1, 2016 | 11043000 | 152381 |
| Sunday, January 1, 2017 | 327000 | 152381 |
| Monday, January 1, 2018 | 8198000 | 152000 |
| Tuesday, January 1, 2019 | 35219000 | 152000 |
| Wednesday, January 1, 2020 | 46551000 | 152000 |
| Friday, January 1, 2021 | 439442000 | 6689000 |
| Saturday, January 1, 2022 | 722683000 | 2785000 |
| Sunday, January 1, 2023 | 232284000 | 233662000 |
Data in motion
In the competitive world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Dynavax Technologies Corporation and TG Therapeutics, Inc. have been on divergent paths. Dynavax, with its focus on innovative vaccines, saw a staggering 6,450% increase in revenue from 2014 to 2022, peaking at $723 million in 2022. This growth was driven by their strategic pivot towards vaccine development, particularly during the global health crisis.
In contrast, TG Therapeutics, Inc., primarily focused on developing treatments for cancer and autoimmune diseases, experienced a more modest revenue trajectory. Despite a significant leap in 2023, reaching $234 million, their revenue remained relatively flat in earlier years. This disparity highlights the varying impacts of market focus and strategic decisions in the biotech sector. As these companies continue to innovate, their financial journeys offer valuable insights into the dynamics of the industry.
Novo Nordisk A/S vs Dynavax Technologies Corporation: Annual Revenue Growth Compared
Amgen Inc. and Dynavax Technologies Corporation: A Comprehensive Revenue Analysis
Revenue Insights: Gilead Sciences, Inc. and Dynavax Technologies Corporation Performance Compared
Who Generates More Revenue? Alnylam Pharmaceuticals, Inc. or Dynavax Technologies Corporation
Revenue Showdown: United Therapeutics Corporation vs Dynavax Technologies Corporation
Breaking Down Revenue Trends: Sarepta Therapeutics, Inc. vs Dynavax Technologies Corporation
Exelixis, Inc. vs TG Therapeutics, Inc.: Annual Revenue Growth Compared
TG Therapeutics, Inc. vs ADMA Biologics, Inc.: Annual Revenue Growth Compared
Who Generates More Revenue? TG Therapeutics, Inc. or ImmunityBio, Inc.
Breaking Down Revenue Trends: Merus N.V. vs Dynavax Technologies Corporation
Comparing Revenue Performance: Ligand Pharmaceuticals Incorporated or Dynavax Technologies Corporation?
Revenue Insights: Dynavax Technologies Corporation and Galapagos NV Performance Compared